
Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.

Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.

According to the agency, this new authority may improve access to patients at high risk for severe COVID-19.

Ruling comes in cases with prison sentences for convictions over prescription drugs.

The bill allows state attorneys general and the Federal Trade Commission the ability to initiate legal action against certain PBM business practices.